BMY beats EPS estimates but misses revenue guidance. Growth portfolio shines, but watch R&D risks.
HGV beats revenue/EPS estimates! Margin leaps on cost cuts & new buyers. Outlook strong.
ATI beats EPS estimates despite flat sales; margins rise on aerospace/defense focus. Buy?
Hyatt Hotels (H) beats Q1 revenue/EPS estimates. Strong luxury demand & loyalty growth offset regional risks. Buy?
LLY beats Q1 estimates with 55.5% revenue growth; guidance raised. Buy LLY?
CROX beats EPS estimates despite sales dip. Guidance up, but margins face tariff/cost headwinds.
FANG up 30%, CVX up 20%. FANG's yield 2.1%, CVX's 3.8%. CVX offers better value.
Sponsored
Must Read